res m glp 1 postbiotic resbiotic debuts resM GLP-1 for natural weight management Struggling with cravings? 🍽️ resM

Researchers also associate ending GLP-1 therapy before pregnancy with a few risks.* Women who stopped taking a GLP-1 RA before or during early pregnancy had roughly 1.3x the risk of preterm birth, gestational diabetes, and high blood pressure conditions during pregnancy, compared to similar women who had not taken a GLP-1 RA

Currently, the majority of systematic reviews are devoted to the impact of GLP-1 receptor agonists on the effects on weight and metabolism causes, although there is still no systematic evidence of their psychiatric adverse effects [23].Specifically, since depression is a mental consequence with the low incidence rate and is affected by a variety of determinants, its evaluation demands higher level of statistical power and analysis of studies across different studies [24, 25]

Patel et al., Vitamins, Amino Acids, and Drugs and Formulations Used in Nutrition, 2016, pp

References Nguyen, L